Healthcare policy sits at the intersection of science, economics, and human welfare—making it one of the most complex and consequential areas of public policy. Our healthcare coverage cuts through partisan rhetoric and industry spin to examine how medical innovations, insurance reforms, and regulatory decisions actually affect patients, providers, and taxpayers. From analyzing Medicare negotiations and FDA approval processes to investigating health disparities and pharmaceutical pricing, we provide the evidence-based context needed to understand why healthcare remains America’s most persistent policy challenge.
Our approach combines rigorous data analysis with clear explanations of technical concepts, ensuring that complex medical and economic realities become accessible to informed readers. Whether exploring the unintended consequences of well-intentioned reforms or examining promising innovations in care delivery, these articles maintain our commitment to intellectual honesty—acknowledging uncertainty where it exists while highlighting the human stakes involved in every policy debate.
-
Technology’s Promise: How AI and Digital Health Could Transform Healthcare Economics
Part 6 of “The Business Model of Healthcare: From Costs to Cures” The healthcare industry has long been a paradox: a sector defined by life-saving innovation that is simultaneously shackled… Read More…
-
The $2.6 Billion Drug: Understanding Pharmaceutical Economics
Part 3 of “The Business Model of Healthcare: From Costs to Cures” series Industry-cited averages to “bring a drug to market” often trace to Tufts Center estimates of roughly $2.6… Read More…
-
The Healthcare Value Paradox: Why America Pays More and Gets Less
Update: 2023–2024 data show the U.S. still spends far more than peers—driven by prices and administrative complexity—while underperforming on access, equity, and outcomes. Unless noted, U.S. figures are 2023 CMS/KFF;… Read More…





